Tuany Eichwald
Anknuten till Forskning
E-postadress: tuany.eichwald@ki.se
Besöksadress: Solnavägen 9, Biomedicum, 17165 Solna
Postadress: C3 Fysiologi och farmakologi, C3 FyFa M Neuroimmunologi, 171 77 Stockholm
Artiklar
- Journal article: NATURE. 2025;:1-12Baruch EN; Gleber-Netto FO; Nagarajan P; Rao X; Akhter S; Eichwald T; Xie T; Balood M; Adewale A; Naara S; Sathishkumar HN; Islam S; McCarthy W; Mattson BJ; Ferrarotto R; Wong MK; Davies MA; Jindal S; Basu S; Roversi K; Nikpoor AR; Ahmadi M; Ahmadi A; Harwood C; Leigh I; Gong D; Tallon de Lara P; Tao DL; Davidson TM; Ajami NJ; Futreal A; Rai K; Kochat V; Castillo M; Gunaratne P; Goepfert RP; Hernandez SD; Khushalani NI; Wang J; Watowich SS; Calin GA; Migden MR; Yuan M; Liu N; Ye Y; Hwang WL; Vermeer PD; D'Silva NJ; Bunimovich YL; Yaniv D; Burks JK; Gomez J; Dougherty PM; Tsai KY; Allison JP; Sharma P; Wargo JA; Myers JN; Talbot S; Gross ND; Amit M
- Journal article: SCIENCE SIGNALING. 2025;18(898):eads7889Restaino AC; Ahmadi M; Eichwald T; Nikpoor AR; Walz A; Balood M; Talbot S; Vermeer PD
- Journal article: NATURE REVIEWS CANCER. 2025;25(8):573-589Amit M; Eichwald T; Roger A; Anderson J; Chang A; Vermeer PD; Dixon KO; Scheff NN; Talbot S
- Journal article: BRAIN SCIENCES. 2025;15(6):646Eichwald T; Scheffer DDL; Barros L; Solano A; Menegassi VDS; Staats Pires AC; Spivakoski CS; Da Silva RA; Gaspar JM; Ronsoni MF; Latini A
- Journal article: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2025;1871(5):167824Huang W-L; Eichwald T; Stover A; Gazanfari M; Schwartz PH; Latini A; Abdenur JE
- Journal article: CANCER RESEARCH. 2024;84(7_Supplement):sy31-02-sy31-02Eichwald T; Balood M; Ahmadi M; Roversi K; Wong D; Mandl J; Rafei M; Ghasemlou N; Vermeer P; Amit M; Talbot S
- Journal article: MOLECULAR GENETICS AND METABOLISM. 2024;141(4):108187Gazanfari M; Huang W-L; Eichwald T; Stover A; Schwartz PH; Latini A; Abdenur J
- Journal article: NEUROTOXICOLOGY. 2023;97:12-24Deza-Ponzio R; Albrecht PA; Fernandez-Hubeid LE; Eichwald T; Cejas RB; Garay YC; Rivera-Meza M; Latini A; Irazoqui FJ; Virgolini MB
- Article: SCIENCE ADVANCES. 2023;9(19):eade4443Restaino AC; Walz A; Vermeer SJ; Barr J; Kovacs A; Fettig RR; Vermeer DW; Reavis H; Williamson CS; Lucido CT; Eichwald T; Omran DK; Jung E; Schwartz LE; Bell M; Muirhead DM; Hooper JE; Spanos WC; Drapkin R; Talbot S; Vermeer PD
- Journal article: ANTIOXIDANTS. 2023;12(5):1037Eichwald T; da Silva LDB; Staats Pires AC; Niero L; Schnorrenberger E; Filho CC; Espíndola G; Huang W-L; Guillemin GJ; Abdenur JE; Latini A
- Journal article: MOLECULAR GENETICS AND METABOLISM. 2023;138(3):107440Latini A; Huang W-L; Eichwald T; Stover A; Schwartz P; Abdenur J
- Journal article: ANTIOXIDANTS. 2023;12(3):554Eichwald T; Solano AF; Souza J; de Miranda TB; Carvalho LB; Sanna PLDS; da Silva RAF; Latini A
- Article: NATURE. 2022;611(7935):405-412Balood M; Ahmadi M; Eichwald T; Ahmadi A; Majdoubi A; Roversi K; Roversi K; Lucido CT; Restaino AC; Huang S; Ji L; Huang K-C; Semerena E; Thomas SC; Trevino AE; Merrison H; Parrin A; Doyle B; Vermeer DW; Spanos WC; Williamson CS; Seehus CR; Foster SL; Dai H; Shu CJ; Rangachari M; Thibodeau J; Del RSV; Drapkin R; Rafei M; Ghasemlou N; Vermeer PD; Woolf CJ; Talbot S
- Journal article: FREE RADICAL BIOLOGY AND MEDICINE. 2022;192:85Cruz L; Pasa T; Scheffer D; Eichwald T; Stover A; Schwartz P; Huang W-L; Walz R; De Paul AL; Abdenur J; Latini A
- Journal article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022;149(2):ab132Eichwald T; Wang J-C; Poirier F; Crosson T; Ahmadi M; Balood M; Ahmadi A; Roversi K; Talbot S
- Journal article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022;149(2):ab12Crosson T; Eichwald T; Roversi K; Ahmadi M; Ahmadi A; Balood M; Talbot S
- Journal article: NEUROTOXICITY RESEARCH. 2022;40(1):276-285da Silva EB; Eichwald T; Glaser V; Varela KG; Baptistella AR; de Carvalho D; Remor AP
- Journal article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2021;147(2):ab149Wang J-C; Crosson T; Eichwald T; Roversi K; Ahmadi M; Balood M; Talbot S
- Journal article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2021;147(2):ab54Crosson T; WANG J-C; Roversi K; Eichwald T; Balood M; Ahmadi M; Talbot S
- Journal article: ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH. 2020;27(36):45874-45882Thiel NA; Sachett A; Schneider SE; Garbinato C; Decui L; Eichwald T; Conterato GMM; Latini A; Piato A; Siebel AM
- Journal article: REVISTA BRASILEIRA DE SAÚDE OCUPACIONAL. 2020;45:e1Steffani JA; Wames MMM; Eichwald T; Dallacosta FM; Rossoni C; Cetolin SF
- Journal article: JOURNAL OF INTERNAL MEDICINE. 2019;286(3):268-289Crosson T; Roversi K; Balood M; Othman R; Ahmadi M; Wang J-C; Pereira PJS; Tabatabaei M; Couture R; Eichwald T; Latini A; Prediger RD; Rangachari M; Seehus CR; Fosters SL; Talbot S
- Journal article: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2019;104:98-107Richter Schmitz CR; Eichwaldd T; Branco Flores MV; Varela KG; Mantovani A; Steffani JA; Glaser V; de Carvalho D; Remor AP
- Journal article: PHYSIOLOGY & BEHAVIOR. 2019;204:309-323Barros L; Eichwald T; Solano AF; Scheffer D; da Silva RA; Gaspar JM; Latini A
- Journal article: FRONTIERS IN NEUROSCIENCE. 2019;13:323Formolo DA; Gaspar JM; Melo HM; Eichwald T; Zepeda RJ; Latini A; Okun MS; Walz R
- Journal article: REVISTA INTERDISCIPLINAR DE ESTUDOS EM SAÚDE. 2018;7(2):193-210Flores MVB; Eichwald T; Mantovani A; Glaser V; Schimitz CRR; Rossoni C; Steffani JA; Perinetto D; Carvalho D; Remor AP
- Visa fler
Alla övriga publikationer
- Review: CURRENT OPINION IN IMMUNOLOGY. 2024;91:102507Brabenec L; Gupta S; Eichwald T; Rafei M; Talbot S
- Preprint: BIORXIV. 2024;BIORXIVRestaino AC; Ahmadi M; Nikpoor AR; Walz A; Balood M; Eichwald T; Talbot S; Vermeer PD
- Editorial comment: TRENDS IN IMMUNOLOGY. 2024;45(8):574-576Eichwald T; Talbot S
- Review: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024;153(4):924-938Gupta S; Viotti A; Eichwald T; Roger A; Kaufmann E; Othman R; Ghasemlou N; Rafei M; Foster SL; Talbot S
- Preprint: RESEARCH SQUARE. 2021Talbot S; Balood M; Ahmadi M; Eichwald T; Majdoubi A; Merrison H; Parrin A; Doyle B; Lucido C; Vermeer D; Huang S; Ji L; Dai H; Shu C; Roversi K; Thomas S; Seehus C; Foster S; Ahmadi A; Rafei M; Rangachari M; Thibodeau J; Ghasemlou N; Rincon SD; Drapkin R; Vermeer P; Woolf C
- Review: FRONTIERS IN HUMAN NEUROSCIENCE. 2020;14:181Eichwald T; Talbot S
- Preprint: BIORXIV. 2020Kovacs A; Vermeer D; Madeo M; Reavis H; Vermeer S; Williamson C; Rickel A; Stamp J; Lucido C; Cain J; Bell M; Morgan M; Yoon J-Y; Mitchell M; Tulina N; Stuckelberger S; Budina A; Omran D; Jung E; Schwartz L; Eichwald T; Hong Z; Weimer J; Hooper J; Godwin A; Talbot S; Drapkin R; Vermeer P
- Preprint: SSRN ELECTRONIC JOURNAL. 2020Balood M; Ahmadi M; Majdoubi A; Eichwald T; Merrison H; Parrin A; Doyle B; Vermeer D; Wang C-C; Thanawala M; Roversi K; Thomas SC; Seehus CR; Foster SL; Latini A; Rafei M; Rangachari M; Del Rincon S; Shu CJ; Drapkin R; Thibodeau J; Woolf CJ; Vermeer PD; Talbot S
Forskningsbidrag
- Brain Canada Foundation1 April 2024Melanoma brain metastases (MBMs) are a serious issue affecting up to half of all patients with stage IV melanoma, typically leading to a poor outlook. While immune therapy using anti-PD-1 can help, it only works for about 20% of MBM patients, which is much lower than the response seen in other melanoma patients who don’t have cancer affecting the brain. A combination of anti-PD-1 and anti-CTLA-4 therapies has shown some promise, with about half of patients responding well, though it does come with higher side effects. This combination treatment also loses its effectiveness for those with more severe MBMs. The unique environment in the brain for these tumors demands focused research. Recent studies have shown that the nervous system and immune system influence each other in complex ways. The peripheral nervous system impacts blood cell production, while the central nervous system manages inflammation and immune memory in other organs. Damage to nerves draws in macrophages, a type of immune cell, to help with healing. These cells play a role in cancer growth and in resistance to anti-PD-1 therapy. Studies have shown that these tumors can cause nerve damage which makes them resistant to common treatments. Patients whose tumors have spread into surrounding nerve tissues often do not respond well to therapy. Research has also shown that such nerve damage can trigger a series of immune responses that end up tiring out the cells meant to fight the tumor. Some experimental treatments in mice, like specifically turning off certain genes in nerves within the tumors, have shown that managing this nerve damage could potentially enhance the effectiveness of immune therapies. These discoveries are guiding new clinical trials that aim to improve treatment for brain tumor patients by specifically targeting the interactions between nerves and the immune system in tumors.